Skip to content

Clinical trials

Phase 1/2 alpha 1-Antitrypsin Deficiency trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: alpha 1-Antitrypsin Deficiency Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20141
20162
20172
20211
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Not yet recruiting1
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grifols Therapeutics LLC3
Baxalta now part of Shire2
Adverum Biotechnologies, Inc.1
Beam Therapeutics Inc.1
CRISPR Therapeutics1
Intellia Therapeutics1
Korro Bio, Inc.1
Medical University of South Carolina1
Soroka University Medical Center1
Tessera Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
alpha 1-Antitrypsin Deficiency14
Lung Diseases3
Emphysema2
Pulmonary Disease, Chronic Obstructive2
Digestive System Diseases1
Genetic Diseases, Inborn1
Inflammation1
Liver Diseases1
Lung Diseases, Obstructive1
Pancreatitis, Chronic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.